Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Healthcare investment fund founded:

This article was originally published in Clinica

Executive Summary

Henry Wendt, the retired SmithKline Beecham chairman who piloted its 1989 merger, is one of a line-up of healthcare managers who have set up the Finisterre fund, a private equity investment fund working exclusively in the healthcare products industry. Finisterre intends to acquire "foundation" companies and then to build each of them through strategic acquisition of related companies and products. By "foundation" company the group means one with at least $50 million in revenue, with operating profits and products essential to patient health. The fund says it can make large acquisitions of up to $1,000 million.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT093333

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel